Investor advisory firms back Takeda’s $62 billion deal for Shire

Two shareholder advisory firms have backed Takeda Pharmaceutical’s $62 billion takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal.

…read more

Source:: Reuters – Business News


Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.